Immunization of Children Infected with Human T-Lymphotropic Virus type Iii/Lymphadenopathy-Associated Virus
&na, &na; ,,
The Pediatric Infectious Disease Journal 6(2): 209-211
1987
DOI: 10.1097/00006454-198702000-00014Document Number: 350380
Document emailed within 0-6 h
Related Documents
1985: Leads from the MMWR. Heterosexual transmission of human T-lymphotropic virus type III/lymphadenopathy-associated virus JAMA 254(15): 2051-20521985: Recommendations for preventing transmission of infection with human T-lymphotropic virus type III/lymphadenopathy-associated virus in the workplace Mmwr. Morbidity and Mortality Weekly Report 34(45): 681
Nicholson, J.K.; Cross, G.D.; Callaway, C.S.; McDougal, J.S. 1986: In vitro infection of human monocytes with human T lymphotropic virus type III/lymphadenopathy-associated virus (HTLV-III/LAV) Journal of Immunology 137(1): 323-329
Sierra Madero, J.G.; Ponce de León, S.; Ruiz Palacios, G.; Tinoco, J.C.; Calva, J.J.; Zamora, E.E. 1986: Prevalence of antibodies against the lymphadenopathy-associated virus/human T-cell lymphotropic virus type IIi (LAV/HTLV) in a population of homosexuals in Mexico Salud Publica de Mexico 28(2): 180-185
Sierra Madero, J.G.; Ponce de León, S.; Ruiz Palacios, G.; Tinoco, J.C.; Calva, J.J.; Zamora, E.E. 1986: Prevalence of antibodies against the lymphadenopathy-associated virus/human T-cell lymphotropic virus type IIi (LAV/HTLV) in a population of homosexuals in Mexico Salud Publica de Mexico 28(2): 180-185
Kaplan, J.E.; Oleske, J.M.; Getchell, J.P.; Kalyanaraman, V.S.; Minnefor, A.B.; Zabala-Ablan, M.; Joshi, V.; Denny, T.; Cabradilla, C.D.; Rogers, M.F. 1985: Evidence against transmission of human T-lymphotropic virus/lymphadenopathy-associated virus (HTLV-III/LAV) in families of children with the acquired immunodeficiency syndrome Pediatric Infectious Disease 4(5): 468-471
Kaplan, J.E.; Oleske, J.M.; Getchell, J.P.; Kalyanaraman, V.S.; Minnefor, A.B.; Zabala-Ablan, M.; Joshi, V.; Denny, T.; Cabradilla, C.D.; Rogers, M.F. 1985: Evidence against transmission of human T-lymphotropic virus/lymphadenopathy-associated virus (HTLV-III/LAV) in families of children with the acquired immunodeficiency syndrome Pediatric Infectious Disease 4(5): 468-471
Jason, J.; McDougal, J.S.; Holman, R.C.; Stein, S.F.; Lawrence, D.N.; Nicholson, J.K.; Dixon, G.; Doxey, M.; Evatt, B.L. 1985: Human T-lymphotropic retrovirus type III/lymphadenopathy-associated virus antibody. Association with hemophiliacs' immune status and blood component usage JAMA 253(23): 3409-3415
Ohba, N.; Matsumoto, M.; Sameshima, M.; Kabayama, Y.; Nakao, K.; Unoki, K.; Uehara, F.; Kawano, K.; Maruyama, I.; Osame, M. 1989: Ocular manifestations in patients infected with human T-lymphotropic virus type i Japanese Journal of Ophthalmology 33(1): 1-12
Scholz, C.; Freeman, G.J.; Greenfield, E.A.; Hafler, D.A.; Höllsberg, P. 1996: Activation of human T cell lymphotropic virus type I-infected T cells is independent of B7 costimulation Journal of Immunology 157(7): 2932-2938
Anon 1985: Instruction sheet no 43 acquired immune deficiency syndrome acquired immune deficiency syndrome in lymphadenopathy associated virus human t cell lymphotropic virus type iii infections recommendations for doctors Hygiene: 523-527
Et Al 1986: Three year incidence of acquired immune deficiency syndrome in five cohorts of human t lymphotropic virus type iii infected risk group members Science 231(4741): 992-995
Kobayashi, T.; Miwa, H.; Uchida, T.; Matsuoka, N.; Kita, K.; Shirakawa, S. 1989: Surface and cytoplasmic expression of CD2, CD13, and CD25 antigens in human T lymphotropic virus type I infected cell line. An immunoelectron microscopic study Laboratory Investigation; A Journal of Technical Methods and Pathology 60(3): 370-374
Pedroso, C.él.; Netto, E.M.; Weyll, N.; Brites, C. 2011: Coinfection by HIV-1 and human lymphotropic virus type 1 in Brazilian children is strongly associated with a shorter survival time Journal of Acquired Immune Deficiency Syndromes 57(Suppl 3): S208-S211
Takeoka, H.; Furusyo, N.; Toyoda, K.; Murata, M.; Sagara, Y.; Kashiwagi, S.; Hayashi, J. 2007: Antibody to the human T-lymphotropic virus type 1 (HTLV-1) envelope protein Gp46 in patients co-infected with HCV and HTLV-1 American Journal of Tropical Medicine and Hygiene 77(1): 192-196
Ohtsubo, H.; Arima, N.; Matsushita, K.; Hidaka, S.; Fujiwara, H.; Arimura, K.; Kukita, T.; Fukumori, J.; Matsumoto, T.; Eizuru, Y.; Tanaka, H. 1997: Human T lymphotropic virus-type I Tax induction of CD21/Epstein-Barr virus receptor expression on T cells and its significance in leukemogenesis of adult T cell leukemia Experimental Hematology 25(12): 1246-1252
Berntorp, E.; Jarevi, G.; Vedback, A.; Nilsson, I.M. 1986: Living adenovirus type 4 vaccine human t lymphotropic virus type iii antibodies in swedish hemophiliacs in relation to type and dosage of factor concentrate Thrombosis Research (Suppl 6): 18
Machado, A.A.; Hirsch, I.; Figueiredo, J.F.; Martinez, R.; de Freitas-Silva, G.; Chermann, J.C.; Covas, D.T. 1996: Occurrence of false positives in tests with synthetic peptides for the analysis of antibodies against the human immunodeficiency virus type 2 (HIV-2) in Brazilian patients infected with the human immunodeficiency virus type 1 (HIV-1) Revista da Sociedade Brasileira de Medicina Tropical 29(6): 615-617
Wong-Staal, F.; Shaw, G.M.; Hahn, B.H.; Salahuddin, S.Z.; Popovic, M.; Markham, P.; Redfield, R.; Gallo, R.C. 1985: Genomic diversity of human T-lymphotropic virus type III (HTLV-III) Science 229(4715): 759-762
Lefrère, J.J. 2000: Human T-lymphotropic virus type i (HTLV-I): risk of transmission with transfusion Presse Medicale 29(20): 1134-1138